Mitochondrial Dynamics and Quality Control
The preceding models treat mitochondria as a homogeneous enzyme pool. In reality, individual mitochondria vary in functional capacity, and cellular energy production depends on the balance between healthy and damaged organelles maintained by quality control processes: fission (division), fusion (merging), mitophagy (selective removal of damaged mitochondria), and biogenesis (creation of new mitochondria).
1 Fission–Fusion Balance
Mitochondrial morphology is dynamically regulated. Fusion (mediated by mitofusins MFN1/2 and OPA1) creates interconnected networks that share metabolites and buffer local damage. Fission (mediated by DRP1) segregates damaged portions for removal by mitophagy. The model tracks healthy (\(M_h\)) and damaged (\(M_d\)) mitochondrial mass:
\[ \begin{aligned} \frac{d M_h}{d t} &= J_{\text{biogenesis}} + k_{\text{fusion}} \cdot M_h \cdot M_d \cdot p_{\text{rescue}} - k_{\text{fission}} \cdot M_h \cdot r_{\text{damage}}([\text{ROS}]) - d_h M_h \\ \frac{d M_d}{d t} &= k_{\text{fission}} \cdot M_h \cdot r_{\text{damage}}([\text{ROS}]) + k_{\text{fusion}} \cdot M_h \cdot M_d \cdot (1 - p_{\text{rescue}}) - J_{\text{mitophagy}} - d_d M_d \end{aligned} \tag{1}\]
where \(J_{\text{biogenesis}}\) is the rate of new mitochondrial production (regulated by PGC-1\(\alpha\), itself activated by AMPK and SIRT1), \(p_{\text{rescue}}\) is the probability that fusion with a healthy mitochondrion rescues a damaged one, \(r_{\text{damage}}([\text{ROS}])\) is the ROS-dependent damage rate, and \(J_{\text{mitophagy}}\) is the rate of selective removal of damaged mitochondria via the PINK1/Parkin pathway.
2 Mitophagy and PINK1/Parkin Pathway
Mitophagy rate depends on both the signal (PINK1 accumulation on depolarized mitochondria) and the cellular capacity for autophagy:
\[ J_{\text{mitophagy}} = v_{\text{mitophagy}} \cdot \frac{M_d}{K_{\text{PINK1}} + M_d} \cdot \frac{[\text{ATP}]}{K_{\text{ATP,autophagy}} + [\text{ATP}]} \tag{2}\]
The ATP dependence is critical: autophagy is an energy-requiring process. When ATP is depleted (as in ME/CFS), mitophagy is impaired, allowing damaged mitochondria to accumulate despite adequate PINK1 signaling. This creates a quality control failure—an insight that emerges only from the coupled model: the cell cannot remove its malfunctioning organelles because the energy required for cleanup is precisely what the malfunctioning organelles fail to produce. Verbal reasoning identifies the paradox qualitatively; the model quantifies the threshold \([\text{ATP}]_{\text{crit,autophagy}}\) below which quality control collapses, producing a sharp transition from manageable damage to runaway accumulation.
3 Biogenesis and PGC-1α Regulation
Mitochondrial biogenesis is regulated by PGC-1\(\alpha\), which is activated by AMPK (sensing energy deficit) and SIRT1 (sensing \(\text{NAD}^\text{+}\) availability):
\[ J_{\text{biogenesis}} = v_{\text{bio}} \cdot \frac{[\text{AMPK}_a]}{K_{\text{AMPK}} + [\text{AMPK}_a]} \cdot \frac{[\text{NAD}^+]}{K_{\text{SIRT1}} + [\text{NAD}^+]} \tag{3}\]
where \([\text{AMPK}_a]\) is activated AMPK (which increases when the AMP/ATP ratio rises). In ME/CFS, biogenesis faces a paradox: energy deficit activates AMPK (promoting biogenesis) but depletes \(\text{NAD}^\text{+}\) (inhibiting SIRT1-mediated PGC-1\(\alpha\) deacetylation). The model resolves this competing-signal problem quantitatively: the net biogenesis rate is a product of two Hill functions with opposing dependencies on energy status. The model predicts patient-specific outcomes: patients with preserved \(\text{NAD}^\text{+}\) pools maintain biogenesis and stabilize (\(J_{\text{biogenesis}} > J_{\text{mitophagy,eff}}\)), while those with severe \(\text{NAD}^\text{+}\) depletion (\(\gamma < 0.7\)) lose the ability to replace damaged mitochondria, crossing a tipping point into progressive decline. This threshold cannot be identified by verbal reasoning because it depends on the precise shape of both Hill functions and their interaction.
The effective \(V_{max}\) of each ETC complex in the energy production model (ATP Production Models) is now proportional to healthy mitochondrial mass: \(V_{max, \text{CI}}^{\text{eff}} = \alpha_{\text{CI}} \cdot V_{max, \text{CI}} \cdot M_h / M_{\text{total}}\). This coupling means that the fission–fusion–mitophagy–biogenesis cycle directly determines energy production capacity on timescales of days to weeks, bridging the gap between acute metabolic dynamics (hours) and long-term disease progression (months).
ME/CFS persistence reflects a failure of mitochondrial quality control rather than ongoing external damage. The energy deficit created by initial mitochondrial injury impairs both mitophagy (ATP-dependent) and biogenesis (\(\text{NAD}^\text{+}\)-dependent), preventing replacement of damaged organelles. This self-maintaining loop—identified through the coupled ODE model (mito dynamics and biogenesis)—predicts that: (1) interventions targeting mitophagy directly (urolithin A, spermidine) may break the cycle even without addressing the original trigger; (2) \(\text{NAD}^\text{+}\) precursor supplementation should improve biogenesis markers (mtDNA copy number, PGC-1\(\alpha\) activity) before improving energy capacity; and (3) patients with preserved mitophagy flux (measurable via mitophagy reporters in lymphocytes) should have better prognosis.
Certainty: 0.40. The quality control framework is well-established in mitochondrial biology and neurodegenerative disease, but its specific application to ME/CFS awaits direct measurement of mitophagy and biogenesis rates in patient tissues.